img-1501669549334
Program at a Glance
Do not miss the Program at a Glance
img-1501669549334
Photo Gallery
Check out the INS Meeting Photo Gallery
img-1501669549334
CE Workshops
CE workshops are available now
img-1501669549334
Registration
Registration for INS Meeting is open now

A case-based method for telling MCI apart from typical ageing

Working out whether an older patient has mild cognitive impairment or simply the expected slip-ups of ageing is one of the most common diagnostic puzzles in Australian general practice. Memory lapses, word-finding hesitations, and slowed processing speed appear in both groups, yet the follow-up pathways differ sharply.

Dementia Australia estimates that roughly half of the 400,000-plus Australians living with dementia remain undiagnosed. Many sit in the grey zone between healthy ageing and a clinical syndrome, where careful case formulation can make the difference between timely intervention and missed opportunity.

A case-based approach helps clinicians weigh collateral history, bedside tests, imaging, and blood results into a coherent impression rather than relying on a single cut-off. Each presentation becomes a small research project: generate hypotheses, test them against evidence, and revise as the picture clarifies.

The sections that follow work through these building blocks, drawing on Australian data sources, Royal Australian College of General Practitioners guidance, and the Australian Imaging, Biomarkers and Lifestyle cohort.

Why case material anchors clinical reasoning

Cognitive performance sits on a continuum, and arbitrary thresholds fail to capture lived experience. A 78-year-old scoring 26/30 on the MoCA may still have early impairment if they were previously a high-functioning academic, while a 72-year-old with the same score and a long stable baseline may simply be ageing within normal limits. Case material forces clinicians to hold these nuances together.

No single neuropsychological test can shoulder this weight. Memory clinics in Sydney, Melbourne, and Brisbane routinely combine domain-specific testing with mood screens, medication reviews, and informant questionnaires. The case narrative weaves these strands into one decision rather than leaving the clinician to reconcile disparate reports.

Practically, this means asking what has changed, over what period, in what contexts, and witnessed by whom, rather than fixating on the raw score. Australian patients often use expressions such as "my memory's gone to the dogs" or "I'm having more senior moments," and these colloquialisms can carry diagnostic weight when probed gently.

Subjective cognitive decline versus objective findings

Subjective cognitive decline describes self-perceived worsening in memory without measurable deficits on standard testing. Many Australians in their sixties and seventies experience this, particularly during stressful transitions such as retirement or bereavement. AIBL data show that around a third of older adults reporting subjective decline progress to measurable impairment within five years, but most do not.

Objective findings require performance at least 1 to 1.5 standard deviations below age- and education-adjusted norms in one domain, with preserved everyday function. The distinction matters because subjective complainers benefit mainly from reassurance and monitoring, while those meeting MCI criteria warrant structured follow-up.

A useful heuristic is to treat the patient's report as a hypothesis and the corroborating history as the first test. An informant who has noticed changes in medication management, appointment keeping, or driving safety adds more weight than self-report alone, particularly in culturally diverse communities where stoicism may discourage open complaint.

Biomarkers, imaging, and the Australian context

When clinical assessment is ambiguous, biomarkers can tilt the balance. The AIBL study, run from Melbourne and Perth, has shown that amyloid PET and CSF Aβ42 concentrations predict progression from MCI to Alzheimer's disease with reasonable accuracy. These investigations are not rebated under Medicare for most patients, restricting use to private cognitive clinics and research settings.

More accessible tools include structural MRI, which may reveal medial temporal atrophy, and serum tests for reversible contributors such as B12, folate, and thyroid function. The RACGP red book recommends a standard workup before specialist referral, including these bloods, a mood screen, and a medication review focused on anticholinergic burden.

In remote and regional Australia, where travel to a memory clinic may mean a 1,500-kilometre flight, telehealth cognitive assessments have expanded access. Many rural GPs now use validated videoconferencing protocols that mirror in-person testing.

Functional independence as the clinical threshold

The line that most reliably separates MCI from dementia is everyday function. Someone with MCI remains independent in basic and instrumental activities, even if they take longer to balance the chequebook or repeat a story. Once managing medications, handling finances, or driving safely begins to fail, the picture shifts toward dementia.

This functional lens shapes referral decisions in Australia. Medicare Benefits Schedule items can be claimed during extended primary care consultations, while specialist referrals typically require documented functional decline with specific examples, dates, and witnesses.

Domain Normal ageing Mild cognitive impairment
Subjective memory Occasional lapses Increasing forgetfulness noticed by patient and family
Objective testing Within age-adjusted norms 1–1.5 SD below norm in one or more domains
Everyday function Independent, possibly slower Largely independent, mild inefficiency with complex tasks
Insight Intact Usually preserved, sometimes anxious
Progression Stable over years Variable, higher annual conversion to dementia
Typical Australian management Reassurance, lifestyle advice, annual review Monitoring, vascular risk reduction, consider specialist referral

Crafting the next diagnostic interview

Preparing for the next difficult conversation starts before the patient enters the room. Review prior notes, identify which domains need more probing, and consider whether an informant interview can be scheduled for the same visit. Those attending the Prague meeting will find can’t-miss sessions on differential diagnosis particularly useful.

Build rapport by acknowledging the courage it takes to seek help, then move from open questions to specific behavioural anchors. Ask about driving, finances, medication, and cooking rather than generic memory, and invite a family member to the next appointment where appropriate.

Document not just the scores but the story. A well-kept case record becomes a baseline against which future change is measured, and it is the foundation of ethical, humane neuropsychological care.

The INS 2018 is over...

General Information

Important information about the meeting

Industry

Support and exhibition opportunities

Czech Republic

Beautiful country situated in the very heart of Europe

Contact

How can we help you?
Meeting Venue
img-1501676046170
Prague Congress Centre (KCP)
5.května 65
140 21 Prague 4
Czech Republic
Phone: +420 261 171 111
Website: www.kcp.cz
Copyright © 2017 - GUARANT International spol. s r.o. All rights reserved. Powered by APPTIDE.